GENESYS CAPITAL
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.
GENESYS CAPITAL
Industry:
Biotechnology Health Care Life Science Venture Capital
Founded:
2000-01-01
Status:
Active
Contact:
(416) 598-3328
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Font Awesome Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-16 | Veralox Therapeutics | Genesys Capital investment in Series A - Veralox Therapeutics | 16.6 M USD |
| 2021-05-21 | Giiant Pharma | Genesys Capital investment in Seed Round - Giiant Pharma | 15 M CAD |
| 2021-02-02 | Flosonics | Genesys Capital investment in Venture Round - Flosonics | 14 M USD |
| 2020-09-08 | Inversago Pharma | Genesys Capital investment in Series B - Inversago Pharma | 35 M USD |
| 2020-01-29 | IDbyDNA | Genesys Capital investment in Series B - IDbyDNA | 20 M USD |
| 2019-11-19 | EBT Medical | Genesys Capital investment in Series A - EBT Medical | 10 M USD |
| 2019-04-02 | Fusion Pharmaceuticals | Genesys Capital investment in Series B - Fusion Pharmaceuticals | 105 M USD |
| 2018-07-25 | Inversago Pharma | Genesys Capital investment in Series A - Inversago Pharma | 7 M USD |
| 2018-01-29 | Flosonics | Genesys Capital investment in Seed Round - Flosonics | 5 M USD |
| 2018-01-11 | Adapsyn Bioscience | Genesys Capital investment in Venture Round - Adapsyn Bioscience | N/A |
More informations about "Genesys Capital"
Genesys Capital - Crunchbase Investor Profile & Investments
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of โฆSee details»
Genesys Capital - LinkedIn
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of โฆSee details»
Genesys Capital - Investments, Portfolio & Company Exits
Genesys Capital 's most notable exits include Fusion Pharmaceuticals, Inversago Pharma, and Invitae. Which industries has this organization had the most exits in? Show . Fusion โฆSee details»
Genesys Capital investment portfolio - PitchBook
Genesys Capital General Information Company Description. Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Canada. The firm seeks to invest in early-stage โฆSee details»
Genesys Capital - Synapse Life Science Consortium
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology. We have a proven track record of identifying โฆSee details»
Genesys Capital - The Org
Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of โฆSee details»
Genesys Capital - Investor Profile, Portfolio & Team - Tracxn
Oct 20, 2024 Co-investors of Genesys Capital. Over the past . 21 years, 115 investors have co-invested in Genesys Capital's portfolio companies.. This includes only funds.Invested before โฆSee details»
Genesys Capital - Venbridge
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology. We have a proven track record of identifying emerging bioscience opportunities, and transforming โฆSee details»
Genesys Capital - Funding, Financials, Valuation & Investors
Genesys Capital . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 4. Funding. Genesys โฆSee details»
Genesys Wins the โDeal of the Yearโ Award at ๏ปฟ2024 CVCA Awards
Jun 11, 2024 Genesys Capital won the CVCA 2024 โDeal of the Yearโ award for their investment in Montreal, Quebec-headquartered Inversago Pharma. Genesys led Inversagoโs $7-million โฆSee details»
Genesys Capital - Life science venture capital
Genesys Capital invests in and builds companies in the high-growth sectors of biotechnology, pharmaceuticals and medical technology. We have a proven track record of identifying โฆSee details»
Genesys Capital - Mink Capital
Genesys has generated more than 18 exits from 38 portfolio companies and has invested more than $250M. Our third institutional fund is closed and weโre actively considering new, high โฆSee details»
Genesys (company) - Wikipedia
Genesys was founded by Gregory Shenkman and Alec Miloslavsky in October 1990. [3] [5] The company's original seed funding was $150,000 in loans from the founders' families. [3]The โฆSee details»
Genesys Raises $580 Million in Funding at $21 Billion Valuation
London, Dec. 6, 2021 โ Genesys®, a global cloud leader in customer experience orchestration, today announced a $580 million round of funding, which is intended to accelerate the โฆSee details»
Pacific Smiles takeover saga over as Genesis bid accepted
Nov 22, 2024 At the time, Genesis had secured 29.9 million Pacific Smiles shares, or 18.75 per cent of the issued capital. While Pacific Smiles conceded that the performance of its share โฆSee details»
Genesys Capital - Contacts, Employees, Board Members
Genesys Capital has 5 current employee profiles, including Co-Founder and Managing Director Kelly Holman. Genesys Capital has 1 board member or advisor, John Mendlein. Contacts. Edit โฆSee details»
Genesis crowns Pacific Smiles directors as major shareholder exits
3 days ago A Friday morning ASX announcement showed shrewd private equity suitor Genesis Capital leapt over the 50 per cent threshold to secure majority control and now holds 59.2 per โฆSee details»
Jamie Stiff - Managing Director @ Genesys Capital - Crunchbase
Organization Name . Investor Name . Lead Investor . Funding Round ... Genesys Capital . Yes: Series A - Inversago Pharma . $7M. Jobs. Edit Jobs Section. Number of Current Jobs 5. Jamie โฆSee details»
Paris dreams of becoming the capital of positive AI with the ...
1 day ago France will host 100 heads of state and some 600 business and NGO leaders from the USA and Europe, as well as China and Africa.See details»
Genesis Capital - Crunchbase Investor Profile & Investments
Genesis Capital is the largest institutional digital asset lender, including over $10B in 2020 YTD. Jersey City, New Jersey, United States; 1-10; Venture Capital genesiscap.co/ 38,689; โฆSee details»